ライフサイエンスコーパス: abdominal adipose tissue

1 nd insulin signalling (IRS2) in subcutaneous abdominal adipose tissue.

2 phase transition (freezing/melting) in human abdominal adipose tissue.

3 ng increases IRS2 expression in subcutaneous abdominal adipose tissue.

4 age (SSB) intake has been linked to abnormal abdominal adipose tissue.

5 onsumption was not associated with change in abdominal adipose tissue.

6 e intensity may affect the selective loss of abdominal adipose tissue.

7 seline covariates and change in subcutaneous abdominal adipose tissue.

8 sceral (VAT), but not to subcutaneous (SAT), abdominal adipose tissue.

9 in a significant reduction in the amount of abdominal adipose tissue.

10 ween higher intake of anthocyanins and lower abdominal adipose tissue.

11 nt changes in body composition, particularly abdominal adipose tissue (AAT) deposition patterns, whic

12 rficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in-oppose

13 We investigated associations between abdominal adipose tissue, alterations in kynurenine path

14 ed hand vein and veins draining subcutaneous abdominal adipose tissue and forearm muscle, and arterio

15 assess volumes of visceral and subcutaneous abdominal adipose tissue and liver signal intensity (LSI

16 ast-enhanced ultrasound perfusion imaging of abdominal adipose tissue and skeletal muscle was perform

17 ging-based, semiautomated method to quantify abdominal adipose tissue and thigh muscle volume and hep

18 gh repeatability and accuracy for estimating abdominal adipose tissue and thigh muscle volumes and he

19 Abdominal adipose tissue and thigh muscle were segmented

20 tabolic risk, including waist circumference, abdominal adipose tissue, and hepatic fat content.

21 o the association between aMed scores, lower abdominal adipose tissue, and inflammation.

22 visceral adipose tissue (VAT), subcutaneous abdominal adipose tissue, and total abdominal adipose ti

23 - mice exhibit significantly lower levels of abdominal adipose tissue as compared with the wild-type

24 , ACACA, FATP2, CD36, and G6PC) in liver and abdominal adipose tissues as well as increased IRS1 phos

25 The distribution of abdominal adipose tissue at birth may give insights into

26 ensitivity to catecholamines in subcutaneous abdominal adipose tissue (AT).

27 bserved for each additional 5 HU decrease in abdominal adipose tissue attenuation.

28 qRT-PCR analysis of gene expression in abdominal adipose tissue biopsies was used to develop a

29 ography/mass spectrometry), and subcutaneous abdominal adipose tissue biopsies.

30 s of GIP in glucose metabolism, subcutaneous abdominal adipose tissue blood flow (ATBF), and lipid me

31 suction decreased the volume of subcutaneous abdominal adipose tissue by 44 percent in the subjects w

32 clude that determining the masses of various abdominal adipose tissue compartments at the L2-L3 inter

33 We assessed the influence of ethnicity on abdominal adipose tissue compartments in Asian neonates

34 opometric values were measured at birth, and abdominal adipose tissue compartments were assessed by M

35 method for determining the masses of various abdominal adipose tissue compartments, we studied the pr

36 mass, visceral adipose tissue, subcutaneous abdominal adipose tissue (deep and superficial), insulin

37 ences in the strength of association between abdominal adipose tissue depots and insulin sensitivity

38 eritoneal, retroperitoneal, and subcutaneous abdominal adipose tissue determined on single axial abdo

39 0.01), with a significant increase in intra-abdominal adipose tissue DFA uptake from 0.15 (0.04-0.31

40 ity to metabolic diseases is associated with abdominal adipose tissue distribution and varies between

41 Insulin sensitivity, body composition, and abdominal adipose tissue distribution were assessed with

42 th controlled direct effects of ethnicity on abdominal adipose tissue; dSAT was significantly greater

43 88.4 to 2418.2; P = .0071), and subcutaneous abdominal adipose tissue (estimated difference 28.4 cm(2

44 RNA from subcutaneous abdominal adipose tissue from 9 obese subjects was analy

45 of the E3 ubiquitin ligase Pellino3 in human abdominal adipose tissue from obese subjects and in adip

46 iometry and intra-abdominal and subcutaneous abdominal adipose tissue (IAAT and SAAT) by magnetic res

47 Higher levels of intra-abdominal adipose tissue (IAAT) comprising visceral adip

48 neous abdominal adipose tissue (SAAT), intra-abdominal adipose tissue (IAAT), and liver fat were meas

49 Greater subcutaneous abdominal adipose tissue in obese adults may provide a s

50 an integrative approach to the regulation of abdominal adipose tissue involves feedback from autocrin

51 The accumulation of fat in upper-body (abdominal) adipose tissue is associated with obesity-rel

52 The net rate of abdominal adipose tissue leptin production (mean 3.2 +/-

53 Abdominal adipose tissue leptin production was determine

54 gonists to promote lipolysis in subcutaneous abdominal adipose tissue of obese adolescent girls and w

55 g studies have documented human variation in abdominal adipose tissue patterning.

56 enhanced ultrasound, we investigated whether abdominal adipose tissue perfusion is abnormal in insuli

57 ociation with increased DFA storage in intra-abdominal adipose tissues (r = -0.79, P = 0.05) and redu

58 fat (%BF) (r = 0.42, P < 0.01), subcutaneous abdominal adipose tissue (SAAT) (r = 0.40, P < 0.01), to

59 and fifth lumbar vertebrae) and subcutaneous abdominal adipose tissue (SAAT) by using computed tomogr

60 We evaluated the importance of subcutaneous abdominal adipose tissue (SAAT) inflammation and both pl

61 We measured IAAT and subcutaneous abdominal adipose tissue (SAAT) using computed tomograph

62 ivity (S(i)), visceral fat, and subcutaneous abdominal adipose tissue (SAAT) with weight loss in prem

63 Visceral adipose tissue (VAT), subcutaneous abdominal adipose tissue (SAAT), and hepatic fat fractio

64 visceral adipose tissue (VAT), subcutaneous abdominal adipose tissue (SAAT), and total abdominal adi

65 Subcutaneous abdominal adipose tissue (SAAT), intra-abdominal adipose

66 Visceral adipose tissue and subcutaneous abdominal adipose tissue samples were collected at surgi

67 of measuring both visceral and subcutaneous abdominal adipose tissue (SAT) in association with metab

68 Enlargement of adipocytes from subcutaneous abdominal adipose tissue (SAT), increased intrahepatic l

69 hydrostatic weighing, IAAT and subcutaneous abdominal adipose tissue (SCAAT) by computed tomography,

70 ed molecular responses of human subcutaneous abdominal adipose tissue (SCAT) to 6 weeks of morning fa

71 al)/day for 16 weeks and serial subcutaneous-abdominal-adipose tissue (SCAT) biopsies (weight loss: 2

72 surements for the quantitative assessment of abdominal adipose tissue strongly correlate with clinica

73 s abdominal adipose tissue (SAAT), and total abdominal adipose tissue (TAAT) in mid-childhood (mean a

74 utaneous abdominal adipose tissue, and total abdominal adipose tissue (TAAT) were estimated using DXA

75 sue, including the inability of subcutaneous abdominal adipose tissue to trap and store free fatty ac

76 The primary outcomes were changes in abdominal adipose tissue [visceral (VAT), deep subcutane

77 etary fat interaction on the change in total abdominal adipose tissue, visceral adipose tissue, and S

78 Changes in waist circumference (WC), total abdominal adipose tissue, visceral adipose tissue, and s

79 Abdominal adipose tissue volume and intramyocellular lip

80 Abdominal adipose tissue volume in cm(3) and attenuation

81 iations with lower visceral and subcutaneous abdominal adipose tissue volumes and with lower odds of

82 with clinical measurements for assessment of abdominal adipose tissue volumes in healthy (control sub

83 e, waist circumference change, or respective abdominal adipose tissue volumes.

84 o quantify subcutaneous, visceral, and total abdominal adipose tissue volumes.

85 In PWH, increase in abdominal adipose tissue was associated with increased q

86 Perirenal-abdominal adipose tissue was sampled from ovine fetuses

87 cose homeostasis, and higher body weight and abdominal adipose tissue weight were observed in male of

88 nd quality (attenuation, Hounsfield Unit) of abdominal adipose tissue were measured using computed to

89 Biopsies of subcutaneous abdominal adipose tissue were obtained before and after

90 confirmed by examination of the subcutaneous abdominal adipose tissue which showed that OSA patients

91 ced storage of dietary fatty acids (DFAs) in abdominal adipose tissues with enhanced cardiac partitio